ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

TRIGLIDE
Hyperlipoproteinemias
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

TRIGLIDE Rx

Generic Name and Formulations:
Fenofibrate 160mg; tabs.

Company:
Shionogi, Inc.

Therapeutic Use:

Indications for TRIGLIDE:

Adjunct to diet in severe hypertriglyceridemia, to reduce elevated total-C, LDL-C, apo B, TG, and to increase HDL-C in primary hypercholesterolemia and mixed dyslipidemia.

Limitations Of use:

Fenofibrate did not reduce coronary heart disease morbidity and mortality in 2 controlled trials of patients with type 2 diabetes.

Adult:

Swallow whole. 160mg once daily. Discontinue if inadequate response after 2 months.

Children:

Not established.

Contraindications:

Severe renal impairment. Hepatic impairment. Primary biliary cirrhosis. Unexplained persistent liver function abnormalities. Gallbladder disease. Nursing mothers.

Warnings/Precautions:

The effect on coronary heart disease morbidity and mortality and non-cardiovascular mortality has not been established. Avoid in mild or moderate renal impairment. Monitor CBCs for first year; monitor liver function; discontinue if ALT (SGPT) levels >3xULN persist. Discontinue if markedly elevated CPK levels, myopathy, gallstones, hypersensitivity reactions, or severely depressed HDL-C levels, occur. Pregnancy (Cat.C).

Pharmacological Class:

Fibrate.

Interactions:

Avoid statins. Potentiates oral anticoagulants (monitor). Allow at least 1 hour before or 4–6 hours after bile acid sequestrants. Caution with colchicine, immunosuppressants (eg, cyclosporine, tacrolimus), other nephrotoxic drugs.

Adverse Reactions:

Abnormal liver function tests, elevated CPK, respiratory or GI effects; myopathy, cholelithiasis, pancreatitis, increased serum creatinine, rash; rare: rhabdomyolysis, transient hematologic changes, blood dyscrasias, paradoxical decrease in HDL-C levels, hypersensitivity reactions (may be severe).

How Supplied:

Tabs—30


Data provided by MPR.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs